# OnCo record paper-nccn-breast-cancer-v4-2026-jnccn-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nccn-breast-cancer-v4-2026-jnccn-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nccn-breast-cancer-v4-2026-jnccn-2026" ;
  schema:name "Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology"@en ;
  schema:description "The 2026 journal summary of the US NCCN breast cancer guideline, this version focused on recurrent and metastatic disease and how treatment is chosen by receptor status, prior therapy and time since treatment."@en ;
  schema:url <https://onco.cc/key-papers/paper-nccn-breast-cancer-v4-2026-jnccn-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.6004/jnccn.2026.0033>, <https://pubmed.ncbi.nlm.nih.gov/42425164/>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.6004/jnccn.2026.0033> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Gradishar WJ, Moran MS, Abraham J, et al." ;
  onco:related <https://onco.cc/collections/nccn/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:trials <https://onco.cc/trials/keynote-522/>, <https://onco.cc/trials/ascent-04/>, <https://onco.cc/trials/ascent-03/>, <https://onco.cc/trials/tropion-breast02/> ;
  onco:journals <https://onco.cc/journals/jnccn/> .